Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-25

Clinical Trial Update: Clinical Trial of Vit D and Calcium for Recurrent BPPV [NA]

View source ↗

Summary

This entry details a clinical trial evaluating vitamin D and calcium for recurrent benign paroxysmal positional vertigo, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium carbonate (Calcium carbonate)
  • Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: BPPV, Benign Paroxysmal Positional Vertigo | NA | Status: NOT_YET_RECRUITING